Antibodies for use in agrin deficiency disorders

JP2026518662APending Publication Date: 2026-06-09ARGENX BVBA(BE)
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
ARGENX BVBA(BE)
Filing Date
2024-05-10
Publication Date
2026-06-09

Smart Images

  • Figure 2026518662000020
    Figure 2026518662000020
  • Figure 2026518662000021
    Figure 2026518662000021
  • Figure 2026518662000022
    Figure 2026518662000022
Patent Text Reader

Abstract

The present invention relates to a MuSK antibody-based molecule for use in the prevention or treatment of diseases or conditions caused by agrin deficiency in human subjects.
Need to check novelty before this filing date? Find Prior Art